Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1858 1
1859 1
1861 2
1863 1
1865 1
1875 1
1876 1
1880 1
1885 1
1890 2
1891 1
1892 1
1895 2
1897 1
1898 1
1901 1
1907 1
1912 2
1913 1
1914 1
1916 1
1918 1
1920 2
1921 2
1922 1
1923 2
1925 5
1927 1
1928 4
1929 1
1930 4
1932 1
1934 2
1936 1
1937 2
1941 1
1942 3
1944 2
1945 2
1946 5
1948 3
1949 1
1950 3
1951 5
1952 2
1953 5
1954 3
1955 2
1956 4
1957 2
1958 5
1959 6
1960 11
1961 11
1962 11
1963 14
1964 15
1965 12
1966 40
1967 38
1968 30
1969 29
1970 37
1971 48
1972 44
1973 41
1974 56
1975 301
1976 339
1977 348
1978 305
1979 410
1980 437
1981 439
1982 505
1983 565
1984 669
1985 669
1986 784
1987 813
1988 991
1989 1190
1990 1224
1991 1297
1992 1313
1993 1469
1994 1398
1995 1484
1996 1520
1997 1652
1998 1594
1999 1646
2000 1719
2001 1786
2002 1835
2003 1959
2004 2122
2005 2385
2006 2621
2007 2769
2008 2835
2009 2965
2010 3299
2011 3745
2012 4046
2013 4179
2014 4610
2015 4887
2016 5046
2017 5312
2018 5743
2019 6169
2020 7593
2021 8702
2022 8912
2023 8118
2024 2647

Text availability

Article attribute

Article type

Publication date

Search Results

117,537 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Ray-Shine
Page 1
Targeted in situ genome-wide profiling with high efficiency for low cell numbers.
Skene PJ, Henikoff JG, Henikoff S. Skene PJ, et al. Nat Protoc. 2018 May;13(5):1006-1019. doi: 10.1038/nprot.2018.015. Epub 2018 Apr 12. Nat Protoc. 2018. PMID: 29651053
As only the targeted fragments enter into solution, and the vast majority of DNA is left behind, CUT&RUN has exceptionally low background levels. CUT&RUN outperforms the most widely used chromatin immunoprecipitation (ChIP) protocols in resolution, signal-to …
As only the targeted fragments enter into solution, and the vast majority of DNA is left behind, CUT&RUN has exceptionally low ba …
An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites.
Skene PJ, Henikoff S. Skene PJ, et al. Elife. 2017 Jan 16;6:e21856. doi: 10.7554/eLife.21856. Elife. 2017. PMID: 28079019 Free PMC article.
CUT&RUN is simple to perform and is inherently robust, with extremely low backgrounds requiring only ~1/10th the sequencing depth as ChIP, making CUT&RUN especially cost-effective for transcription factor and chromatin profiling. ...We conclude that in situ …
CUT&RUN is simple to perform and is inherently robust, with extremely low backgrounds requiring only ~1/10th the sequencing depth …
Run Vibrio, run!
Taglialegna A. Taglialegna A. Nat Rev Microbiol. 2023 Sep;21(9):552. doi: 10.1038/s41579-023-00944-9. Nat Rev Microbiol. 2023. PMID: 37433959 No abstract available.
The run chart: a simple analytical tool for learning from variation in healthcare processes.
Perla RJ, Provost LP, Murray SK. Perla RJ, et al. BMJ Qual Saf. 2011 Jan;20(1):46-51. doi: 10.1136/bmjqs.2009.037895. BMJ Qual Saf. 2011. PMID: 21228075
METHODS: A standard approach to the construction, use and interpretation of run charts for healthcare applications is developed based on the statistical process control literature. ...Run charts also provide the foundation for more sophisticated methods of analysis …
METHODS: A standard approach to the construction, use and interpretation of run charts for healthcare applications is developed based …
A Purple Liver.
Jiang G, Pu X, Cao L. Jiang G, et al. Clin Gastroenterol Hepatol. 2022 Nov;20(11):A34. doi: 10.1016/j.cgh.2022.05.036. Epub 2022 Jun 16. Clin Gastroenterol Hepatol. 2022. PMID: 35716903 No abstract available.
CUT&RUN Profiling of the Budding Yeast Epigenome.
Brahma S, Henikoff S. Brahma S, et al. Methods Mol Biol. 2022;2477:129-147. doi: 10.1007/978-1-0716-2257-5_9. Methods Mol Biol. 2022. PMID: 35524116
The intrinsically low background and high resolution of CUT&RUN and CUT&RUN.ChIP allows for identification of transient genomic features such as dynamic nucleosome-remodeling intermediates. Starting from cells, one can perform CUT&RUN or CUT& …
The intrinsically low background and high resolution of CUT&RUN and CUT&RUN.ChIP allows for identification of transien …
Piketty in the long run.
Cowell FA. Cowell FA. Br J Sociol. 2014 Dec;65(4):708-20. doi: 10.1111/1468-4446.12108. Br J Sociol. 2014. PMID: 25516348 Review.
I examine the idea of 'the long run' in Piketty (2014) and related works. In contrast to simplistic interpretations of long-run models of income- and wealth-distribution Piketty (2014) draws on a rich economic analysis that models the intra- and inter-generational p …
I examine the idea of 'the long run' in Piketty (2014) and related works. In contrast to simplistic interpretations of long-run …
High-Resolution Chromatin Profiling Using CUT&RUN.
Hainer SJ, Fazzio TG. Hainer SJ, et al. Curr Protoc Mol Biol. 2019 Apr;126(1):e85. doi: 10.1002/cpmb.85. Epub 2019 Jan 28. Curr Protoc Mol Biol. 2019. PMID: 30688406 Free PMC article.
In CUT&RUN, a recombinant protein A-microccocal nuclease (pA-MN) fusion is recruited by an antibody targeting the chromatin protein of interest; this can be done with either uncrosslinked or formaldehyde-crosslinked cells. ...Here, we describe the methods for performin …
In CUT&RUN, a recombinant protein A-microccocal nuclease (pA-MN) fusion is recruited by an antibody targeting the chromatin prote …
Run-in periods and clinical outcomes of antipsychotics in dementia: A meta-epidemiological study of placebo-controlled trials.
Hulshof TA, Zuidema SU, Gispen-de Wied CC, Luijendijk HJ. Hulshof TA, et al. Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):125-133. doi: 10.1002/pds.4903. Epub 2019 Nov 15. Pharmacoepidemiol Drug Saf. 2020. PMID: 31730266 Free PMC article. Review.
PURPOSE: Run-in periods are used to identify placebo-responders and washout. ...The use of placebo/investigated drug during run-in and run-in duration did not affect the estimates in a consistent way. ...
PURPOSE: Run-in periods are used to identify placebo-responders and washout. ...The use of placebo/investigated drug during run …
Effect of a Run-In Period on Estimated Treatment Effects in Cardiovascular Randomized Clinical Trials: A Meta-Analytic Review.
Murphy RP, O'Donnell MJ, Nolan A, McGrath E, O'Conghaile A, Ferguson J, Alvarez-Iglesias A, Costello M, Loughlin E, Reddin C, Ruttledge S, Gorey S, Hughes D, Smyth A, Canavan M, Judge C. Murphy RP, et al. J Am Heart Assoc. 2022 Oct 18;11(20):e023061. doi: 10.1161/JAHA.121.023061. Epub 2022 Oct 17. J Am Heart Assoc. 2022. PMID: 36250666 Free PMC article. Review.
Methods and Results We conducted a meta-analysis comparing treatment effects from 11 systematic reviews of cardiovascular prevention trials using a run-in period with matched trials not using a run-in period. We matched run-in with non-run-in trials by …
Methods and Results We conducted a meta-analysis comparing treatment effects from 11 systematic reviews of cardiovascular prevention trials …
117,537 results
You have reached the last available page of results. Please see the User Guide for more information.